Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients
Article in Frontiers in Oncology (February 2021)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Cytokine-induced killer cells/natural killer cells combined with anti-GD2 monoclonal antibody increase cell death rate in neuroblastoma SK-N-SH cells
Article in Oncology Letters (October 2019)
Ex vivo expanded patient-derived γδ T-cell immunotherapy enhances neuroblastoma tumor regression in a murine model
Article in OncoImmunology (May 2019)